Teligent Total Assets 2010-2021 | TLGT

Teligent total assets from 2010 to 2021. Total assets can be defined as the sum of all assets on a company's balance sheet.
Teligent Annual Total Assets
(Millions of US $)
2020 $88
2019 $207
2018 $191
2017 $185
2016 $183
2015 $181
2014 $197
2013 $15
2012 $9
2011 $10
2010 $11
2009 $6
Teligent Quarterly Total Assets
(Millions of US $)
2021-06-30 $90
2021-03-31 $101
2020-12-31 $88
2020-09-30 $190
2020-06-30 $190
2020-03-31 $187
2019-12-31 $207
2019-09-30 $196
2019-06-30 $195
2019-03-31 $192
2018-12-31 $191
2018-09-30 $193
2018-06-30 $187
2018-03-31 $181
2017-12-31 $185
2017-09-30 $194
2017-06-30 $196
2017-03-31 $190
2016-12-31 $183
2016-09-30 $187
2016-06-30 $188
2016-03-31 $189
2015-12-31 $181
2015-09-30 $187
2015-06-30 $195
2015-03-31 $200
2014-12-31 $197
2014-09-30 $48
2014-06-30 $16
2014-03-31 $15
2013-12-31 $15
2013-09-30 $12
2013-06-30 $11
2013-03-31 $11
2012-12-31 $9
2012-09-30 $8
2012-06-30 $9
2012-03-31 $9
2011-12-31 $10
2011-09-30 $10
2011-06-30 $10
2011-03-31 $11
2010-12-31 $11
2010-09-30 $6
2010-06-30 $6
2010-03-31 $7
2009-12-31 $6
2009-09-30 $7
2009-06-30 $8
2009-03-31 $10
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.000B $0.000B
Teligent, Inc. is a specialty generic pharmaceutical company, develops, manufactures and markets topical formulations primarily in the United States. It sells generic pharmaceutical products in topical, injectable, complex and ophthalmic dosage forms. Teligent Inc., formerly known as IGI Laboratories, Inc., is based in Buena, New Jersey.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $20.902B 7.10
Dr Reddy's Laboratories (RDY) India $12.399B 18.57
BridgeBio Pharma (BBIO) United States $4.791B 0.00
Bausch Health Cos (BHC) Canada $3.597B 2.61
Amphastar Pharmaceuticals (AMPH) United States $2.469B 13.82
Supernus Pharmaceuticals (SUPN) United States $1.872B 377.44
Taysha Gene Therapies (TSHA) United States $0.314B 51.00
Personalis (PSNL) United States $0.270B 0.00
Assembly Biosciences (ASMB) United States $0.107B 0.00
Acasti Pharma (GRCE) Canada $0.031B 0.00
Sol-Gel Technologies (SLGL) Israel $0.014B 0.00
Evoke Pharma (EVOK) United States $0.005B 0.00